Prescription Dermatological Drugs: Worldwide Market, 6th Edition

Table of Contents

Chapter One: Executive Summary

• Scope and Methodology
• Size and Growth of the Market
• Issues and Trends Affecting Market
• Competitor Analysis

Chapter Two: Introduction

• Structure and Function of the Skin
• Epidermis
• Dermis
• Subcutaneous Tissue
• Epidermal Appendages
  • Functions of the Skin
  • Effects of Aging on the Skin
  • Dermatological Conditions and Treatment
  • Pharmacokinetics
• Drug Absorption
• Distribution
• Bioavailability
  • Drug Delivery Methods
  • Demographics of Skin Disorders, Incidence, and Prevalence

Chapter Three: Issues and Trends

• Cosmetic Dermatologists
• Medicare Reimbursement
• Melanoma Survival Rates Falter
• New Filler Options
• A Confusing Industry
• Genetic Link to Psoriasis
• Biologic Dermatology
• Rx-to-OTC Switches
• Cosmeceuticals
• Antioxidants
• Polypeptides
  • Teledermatology
  • Reimbursement Issues
  • Laser Therapy
  • Narrowband Ultraviolet B
  • Photodynamic Therapy
  • Importance of Drug Delivery

Chapter Four: Prescription Antiacne and Rosacea Drugs

• Description of Disorders
• Description of Products
• Benzoyl Peroxide
  • Description of Products
  • Current Suppliers
• Retinoids
  • Topical Formulations
    • All-trans Retinoic Acid (Tretinoin)
    • Adapalene
    • Tazarotene
  • Systemic Formulations
    • Isotretinoin
  • Current Suppliers
• Antibiotics
  • Description of Products
    • Azelaic Acid
    • Clindamycin
    • Erythromycin
    • Metronidazole
    • Sodium Sulfacetamide
  • Current Suppliers
• Oral Contraceptives
  • Research and Development
  • Market Size and Growth
• Global Market
• Markets by Geographical Region
  • United States
  • Europe
  • Europe
  • Japan
  • Rest of World
• The Future of the Market
• Competitive Analysis

Chapter Five: Prescription Antiaging and Photodamage Drugs

• Overview
• Description of Products
• Keratolytics
• Moisturizers
• Retinoids
• Sunscreens
• Other Agents
  • Market Size and Growth
• Global Market
• Markets by Geographical Region
  • United States
  • Europe
  • Japan
  • Rest of World
• The Future of the Market
• Competitive Analysis

Chapter Six: Prescription Dermatitis and Seborrhea Drugs

• Overview
• Description of Products
• Topical Corticosteroids
• Systemic Corticosteroids
• Other Products
  • Research and Development
  • Market Size and Growth
• Global Market by Type
• Markets by Geographical Region
  • United States
  • Europe
  • Japan
  • Rest of World
• Future of the Market
• Competitive Analysis

Chapter Seven: Prescription Antifungal Drugs

• Overview
• Description of Products
• Systemic Formulations
  • Terbinafine
  • Itraconazole
  • Fluconazole
  • Griseofulvin
  • Ketoconazole
  • Current Suppliers
• Topical Formulations
  • Polyenes
  • Azoles
    • Miconazole
    • Clotrimazole
    • Ketoconazole
    • Oxiconazole
    • Econazole
    • Sulconazole
  • Allylamines and Benzylamines
    • Naftifine
    • Terbinafine
    • Butenafine
  • Other Topical Formulations
  • Current Suppliers
  • Research and Development
  • Market Size and Growth
• Global Market by Type
• Markets by Geographical Region
  • United States
  • Europe
  • Japan
  • Rest of World
• Future of the Market
• Competitive Analysis

Chapter Eight: Prescription Hair Loss and Hair Removal Drugs

• Overview
• Description of Products
• Antiandrogens
• Androgen Inhibitors
• Oral Contraceptives
• Other Treatments
  • Research and Development
  • Market Size and Growth
• Global Market by Type
• Markets by Geographical Region
  • United States
  • Europe
  • Japan
  • Rest of World
• Future of the Market
• Competitive Analysis

Chapter Nine: Prescription Hyperpigmentation/Melasma Drugs

• Overview
• Description of Products
• Research and Development
• Market Size and Growth
• Global Market
• Markets by Geographical Region
• United States
• Europe
• Japan
• Rest of World
  • The Future of the Market
  • Competitive Analysis

Chapter Ten: Prescription Psoriasis Drugs

• Overview
• Description of Products
• Topical Psoriasis Products
  • Anthralin
  • Coal Tar
  • Methoxsalen
  • Second-generation Retinoids
  • Tazarotene
  • Topical Vitamin D
  • Vitamin D Analogs
  • Vanos
• Systemic Psoriasis Preparations
  • Betamethasone
  • Cortisone Acetate
  • Cyclosporine
  • Hydrocortisone
  • Methotrexate
  • Olopatadine Hydrochloride
  • Tacrolimus
• Light Therapy
• Biologics
  • Research and Development
  • Market Size and Growth
• Global Market by Type
• Markets by Geographical Region
  • United States
  • Europe
  • Japan
  • Rest of World
    • Future of the Market
    • Competitive Analysis

Chapter Eleven: Prescription Skin Cancer Drugs

• Overview
• Nonmelanoma Skin Cancers
  • Actinic Keratoses
  • Basal Cell Carcinoma
  • Squamous Cell Carcinoma
  • Cutaneous T-cell Lymphoma
  • Dysplastic Nevus Syndrome
• Malignant Melanoma
• Description of Products
• 5-Fluorouracil
• Mechlorethamine/Nitrogen Mustard
• Carmustine/BCNU (Topical)
• Vinblastine (Intralesional) and Others
• Research and Development
• Market Size and Growth
• Global Market
• Markets by Geographical Region
  • United States
  • Europe
  • Japan
  • Rest of World
• The Future of the Market
• Competitive Analysis

Chapter Twelve: Miscellaneous Skin Disorder Drugs-Antivirals and Antiparasitics

• Overview
  • Antivirals
  • Antiparasitics
• Description of Products
  • Topical Antivirals
  • Antiviral Drugs
  • Immunoenhancing Drugs
  • Current Suppliers
  • Antiparasitic Agents
  • Current Suppliers
• Research and Development
• Market Size and Growth
  • Global Market
  • Markets by Geographical Region
  • United States
  • Europe
  • Japan
  • Rest of World
• The Future of the Market
• Competitive Analysis

Chapter Thirteen: World Market Summary

• Overview
• Total Market Size and Forecast
• Market and Competitive Analysis

Chapter Fourteen: Corporate Profiles

• Allergan Inc.
• Allergan Inamed Corporation
• Barrier Therapeutics, Inc
• Bayer AG
• Bradley Pharmaceuticals, Inc
• Bristol-Myers Squibb
• CollaGenex Pharmaceuticals
• Galderma S.A.
• Genentech, Inc.
• GlaxoSmithKline Plc
• Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
• Medicis Pharmaceutical Corporation
• Merck & Company, Inc.
• Mylan Pharmaceuticals, Inc,
• Novartis Pharmaceuticals Corporation
• Nycomed Inc.
• Pfizer, Inc.
• Q-Med AB
• Roche Group (F. Hoffmann-La Roche Ltd.)
• Schering-Plough Corporation
• Sinclair Pharma Plc.
• SkinMedica
• Stiefel Laboratories, Inc.
• Valeant Pharmaceuticals, Inc.

Appendix: Company Directory

List of Exhibits

Chapter One: Executive Summary

• Table 1-1: The Global Market for Prescription Dermatological Drugs 2002, 2006, and 2011
• Figure 1-1: The Global Market for Prescription Dermatological Drugs 2002, 2006, and 2011

Chapter Two: Introduction

• Table 2-1: Common Bases for Topical Dermatological Medications
• Table 2-2: Worldwide Incidence and Prevalence of Selected Dermatologic Conditions

Chapter Three: Issues and Trends

• Table 3-1: Selected Dermatological Rx-to-OTC Switches
• Table 3-2: Selected Potential Prescription Dermatological Rx-to-OTC Switches

Chapter Four: Prescription Antiacne and Rosacea Drugs

• Table 4-1: Common Benzoyl Peroxide Formulations
• Table 4-2: Common Retinoid Formulations
• Table 4-3: Common Antibiotic Formulations
• Table 4-4: Common Oral Contraceptive Formulations
• Table 4-5: Prescription Acne and Rosacea Formulations in Development
• Table 4-6: The Global Market for Prescription Acne and Rosacea Drugs by Type 2002-2011
• Figure 4-1: The Global Market for Prescription Acne and Rosacea Drugs Revenues by Type 2000-2010
• Figure 4-2: The Global Market for Prescription Acne and Rosacea Drugs Share by Type 2006
• Figure 4-3: The Global Market for Prescription Acne and Rosacea Drugs Share by Type 2011
• Table 4-8: The Global Market for Prescription Antiacne and Rosacea Drugs by Geographical Region 2000-2011
• Figure 4-4: The Global Market for Prescription Antiacne and Rosacea Drugs Revenues by Geographical Region 2000-2011
• Figure 4-5: The Global Market for Prescription Antiacne and Rosacea Drugs Share by Geographical Region 2006
• Figure 4-6: The Global Market for Prescription Antiacne and Rosacea Drugs Share by Geographical Region 2011
• Table 4-14: Global Market for Prescription Antiacne and Rosacea Drugs Revenues and Market Share by Supplier 2006
• Figure 4-7: Global Market for Acne and Rosacea Drugs Market Share by Leading Supplier 2006

Chapter Five: Prescription Antiaging and Photodamage Drugs

• Table 5-1: Common Prescription Keratolytic Formulations
• Table 5-2: Occlusive Moisturizers-Categories of Ingredients
• Table 5-3: Common Prescription Moisturizers
• Table 5-4: Common Prescription Retinoids for Antiaging and Photodamage
• Table 5-5: Common Prescription Sunscreens
• Table 5-6: Other Prescription Antiaging and Photodamage Products
• Table 5-8: The Global Market Antiaging and Photodamage Drugs by Type 2000-2011
• Figure 5-1: The Global Market for Antiaging and Photodamage Drugs Revenues by Type 2000-2011
• Figure 5-2: The Global Market for Antiaging and Photodamage Drugs Share by Type 2006
• Figure 5-3: The Global Market for Antiaging and Photodamage Drugs Share by Type 2011
• Table 5-10: The Global Market for Prescription Antiaging and Photodamage Drugs by Geographical Region 2000-2006
• Figure 5-4: The Global Market for Prescription Antiaging and Photodamage Drugs, Revenues by Geographical Region 2000-2011
• Figure 5-5: The Global Market for Antiaging and Photodamage Drugs Share by Geographical Region 2006
• Figure 5-6: The Global Market for Antiaging and Photodamage Drugs Share by Geographical Region 2011
• Table 5-16: Global Market for Prescription Antiaging and Photodamage Drugs Revenues and Market Share by Supplier 2006
• Figure 5-7: Global Market for Prescription Antiaging and Photodamage Drugs, Market Share by Leading Supplier 2006

Chapter Six: Prescription Dermatitis and Seborrhea Drugs

• Table 6-1: Common Prescription Topical Corticosteroid Preparations
• Table 6-2: Common Prescription Systemic Corticosteroids
• Table 6-3: Prescription Dermatitis Formulations in Development
• Table 6-4: The Global Market for Prescription Dermatitis and Seborrhea Drugs by Type 2000-2011
• Figure 6-1: The Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues by Type 2002-2011
• Figure 6-2: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Type 2006
• Figure 6-3: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Type 2011
• Table 6-6: The Global Market for Prescription Dermatitis and Seborrhea Drugs by Geographical Region 2002-2011
• Figure 6-4: The Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues by Geographical Region 2002-2011
• Figure 6-5: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Geographical Region 2006
• Figure 6-6: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Geographical Region 2011
• Table 6-12: Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues and Market Share by Supplier 2002
• Figure 6-7: Global Market for Prescription Dermatitis and Seborrhea Drugs Market Share by Leading Supplier 2006

Chapter Seven: Prescription Antifungal Drugs

• Table 7-1: Common Prescription Systemic Antifungal Dermatological Formulations
• Table 7-2: Common Prescription Topical Antifungal Dermatological Drugs
• Table 7-3: Prescription Antifungal Dermatological Drugs in Development
• Table 7-4: The Global Market for Prescription Antifungal Dermatological Drugs by Type 2002-2011
• Figure 7-1: The Global Market for Prescription Antifungal Dermatological Drugs Revenues by Type 2002-2011
• Figure 7-2: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Type 2006
• Figure 7-3: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Type 2011
• Table 7-6: The Global Market for Prescription Antifungal Dermatological Drugs by Geographical Region 2002-2006
• Figure 7-4: The Global Market for Prescription Antifungal Dermatological Drugs Revenues by Geographical Region 2002-2006
• Figure 7-5: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Geographical Region 2006
• Figure 7-6: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Geographical Region 2011
• Table 7-12: Global Market for Prescription Antifungal Dermatological Drugs Revenues and Market Share by Supplier 2006
• Figure 7-7: Global Market for Prescription Antifungal Dermatological
• Drugs Market Share by Leading Supplier 2006

Chapter Eight: Prescription Hair Loss and Hair Removal Drugs

• Table 8-1: Common Prescription Hair Loss or Hair Removal Formulations
• Table 8-2: Prescription Hair Loss or Hair Removal Formulations in Development
• Table 8-3: The Global Market for Prescription Hair Loss and Hair Removal Drugs by Type 2002-2011
• Figure 8-1: The Global Market for Prescription Hair Loss and Hair
• Removal Drugs Revenues by Type 2002-2011
• Figure 8-2: The Global Market for Prescription Hair Loss and Hair
• Removal Drugs, Share by Type 2006
• Figure 8-3: The Global Market for Prescription Hair Loss and Hair
• Removal Drugs, Share by Type 2011
• Table 8-5: The Global Market for Prescription Hair Loss and Hair
• Removal Drugs Revenues by Geographical Region 2002-2011
• Figure 8-4: The Global Market for Prescription Hair Loss and Hair
• Removal Drugs Revenues by Geographical Region 2002-2011
• Figure 8-5: The Global Market for Prescription Hair Loss and Hair
• Removal Drugs Share by Geographical Region 2006
• Figure 8-6: The Global Market for Prescription Hair Loss and Hair
• Removal Drugs Share by Geographical Region 2011
• Table 8-11: Global Market for Prescription Hair Loss and Hair Removal Drugs Revenues and Market Share by Supplier 2006
• Figure 8-7: Global Market for Prescription Hair Loss and Hair Removal Drugs Market Share by Leading Supplier 2006

Chapter Nine: Prescription Hyperpigmentation/Melasma Drugs

• Table 9-1: Common Prescription Hyperpigmentation/Melasma
• Formulations
• Table 9-2: Common Prescription Depigmenting Agents
• Table 9-3: The Global Market for Hyperpigmentation/Melasma Drugs by Type 2002-2012
• Figure 9-1: The Global Market for Hyperpigmentation/Melasma Drugs Revenues by Type 2002-2012
• Figure 9-2: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs, Share by Type 2006
• Figure 9-3: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs Share by Type 2011
• Table 9-5: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs by Geographical Region 2002-2011
• Figure 9-4: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs Revenues by Geographical Region 2002-2011
• Figure 9-5: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs, Share by Geographical Region 2006
• Figure 9-6: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs, Share by Geographical Region 2011

Chapter Ten: Prescription Psoriasis Drugs

• Table 10-1: Common Prescription Psoriasis Preparations
• Table 10-2: Prescription Psoriasis Preparations in Development
• Table 10-3: The Global Market for Prescription Psoriasis Drugs by Type 2002-2011
• Figure 10-1: The Global Market for Prescription Psoriasis Drugs Revenues by Type 2002-2011
• Figure 10-2: The Global Market for Prescription Psoriasis Drugs Share by Type 2006
• Figure 10-3: The Global Market for Prescription Psoriasis Drugs Share by Type 2011
• Table 10-5: The Global Market for Prescription Psoriasis Drugs by Geographical Region 2002-2011
• Figure 10-4: The Global Market for Prescription Psoriasis Drugs Revenues by Geographical Region 2002-2011
• Figure 10-5: The Global Market for Prescription Psoriasis Drugs Share by Geographical Region 2006
• Figure 10-6: The Global Market for Prescription Psoriasis Drugs Share by Geographical Region 2011
• Table 10-11: Global Market for Prescription Psoriasis Drugs Revenues and Market Share by Supplier 2006
• Figure 10-7: Global Market for Prescription Psoriasis Drugs Market Share by Leading Supplier 2006

Chapter Eleven: Prescription Skin Cancer Drugs

• Table 11-1: Malignant Conditions of the Skin
• Table 11-2: Common Prescription Topical and Intralesional Chemotherapeutic Agents
• Table 11-3: Prescription Skin Cancer Preparations in Development
• Table 11-4: The Global Market for Skin Cancer Drugs 2002-2011
• Figure 11-1: The Global Market for Skin Cancer Drugs 2002-2011
• Table 11-5: The Global Market for Prescription Skin Cancer Drugs by Geographical Region 2002-2011
• Figure 11-2: The Global Market for Prescription Skin Cancer Drugs Revenues by Geographical Region 2002-2011
• Figure 11-3: The Global Market for Prescription Skin Cancer Drugs
• Share by Geographical Region 2006
• Figure 11-4: The Global Market for Prescription Skin Cancer Drugs Share by Geographical Region 2011
• Table 11-12: Global Market for Prescription Skin Cancer Drugs Revenues and Market Share by Supplier 2006
• Figure 11-9: Global Market for Skin Cancer Drugs Market Share by Leading Supplier 2006

Chapter Twelve: Miscellaneous Skin Disorder Drugs-Antivirals and Antiparasitics

• Table 12-1: Common Prescription Topical Antiviral Formulations
• Table 12-2: Common Prescription Topical Antiparasitic Formulations
• Table 12-3: The Global Market for Prescription Miscellaneous Skin Disorder Drugs by Type 2002-2011
• Figure 12-1: The Global Market for Miscellaneous Skin Disorder Drugs Revenues by Type 2002-2006
• Table 12-5: The Global Market for Prescription Miscellaneous Drugs by Geographical Region 2002-2011
• Figure 12-2: The Global Market for Prescription Miscellaneous Drugs Revenues by Geographical Region 2002-2011
• Figure 12-3: The Global Market for Prescription Miscellaneous Drugs Share by Geographical Region 2006
• Figure 12-6: The Global Market for Prescription Miscellaneous Drugs Share by Geographical Region 2011

Chapter Thirteen: World Market Summary

• Table 13-1: The Global Market for Prescription Dermatological Drugs, Revenues by Segment, 2000-2011
• Figure 13-1: The Global Market for Prescription Dermatological Drugs Revenues by Dermatological Segment, 2002-2011
• Figure 13-2: The Global Market for Dermatological Drugs Market Share by Type 2006
• Figure 13-3: The Global Market for Prescription Dermatological Drugs Market Share by Type 2011
• Table 13-3: Global Market for Prescription Dermatological Drugs Revenues and Segments of Participation by Leading Market Participants 2006